Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors

被引:77
作者
Huhtiniemi, Tero [1 ]
Suuronen, Tiina
Rinne, Valtteri M. [1 ]
Wittekindt, Carsten [1 ]
Lahtela-Kakkonen, Maija [1 ]
Jarho, Elina [1 ]
Wallen, Erik A. A. [1 ]
Salminen, Antero
Poso, Antti [1 ]
Leppanen, Jukka [1 ]
机构
[1] Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland
关键词
D O I
10.1021/jm800639h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new inhibitor for human sirtuin type proteins I and 2 (SIRTI and SIRT2) was discovered through virtual database screening in search of new scaffolds. A series of compounds was synthesized based on the hit compound (3-[[3-(4-tert-butylphenyl) 1,2,4-oxadiazole5 -carbonyl I amino] -I - [3-(tri fluoromethy I)phenyl] thiourea). The most potent compound in the series was nearly as potent as the reference compound (6-chloro-2,3,4,9-tetrahydro-IH-carbazole-l-carboxamide).
引用
收藏
页码:4377 / 4380
页数:4
相关论文
共 22 条
[1]   Identification of a small molecule inhibitor of Sir2p [J].
Bedalov, A ;
Gatbonton, T ;
Irvine, WP ;
Gottschling, DE ;
Simon, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15113-15118
[2]   Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases [J].
Borra, MT ;
Langer, MR ;
Slama, JT ;
Denu, JM .
BIOCHEMISTRY, 2004, 43 (30) :9877-9887
[3]  
*CAMBR CRYST DAT C, GOLD V 3 0
[4]   Phloroglucinol derivatives guttiferone G, aristoforin, and hyperforin:: Inhibitors of human sirtuins SIRT1 and SIRT2 [J].
Gey, Claudia ;
Kyrylenko, Sergiy ;
Hennig, Lothar ;
Nguyen, Lien-Hoa D. ;
Buettner, Anita ;
Pham, Hung D. ;
Giannis, Athanassios .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (27) :5219-5222
[5]   Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes [J].
Heltweg, B ;
Gatbonton, T ;
Schuler, AD ;
Posakony, J ;
Li, HZ ;
Goehle, S ;
Kollipara, R ;
DePinho, RA ;
Gu, YS ;
Simon, JA ;
Bedalov, A .
CANCER RESEARCH, 2006, 66 (08) :4368-4377
[6]   Comparative and pharmacophore model for deacetylase SIRT1 [J].
Huhtiniemi, Tero ;
Wittekindt, Carsten ;
Laitinen, Tuomo ;
Leppanen, Jukka ;
Salminen, Antero ;
Poso, Antti ;
Lahtela-Kakkonen, Maija .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (09) :589-599
[7]   N,N′-bisbenzylidenebenzene-1,4-diamines and N,N′-bisbenzylidenenaphthalene-1,4-diamines as sirtuin type 2 (SIRT2) inhibitors [J].
Kiviranta, Paivi H. ;
Leppanen, Jukka ;
Kyrylenko, Sergiy ;
Salo, Heikki S. ;
Lahtela-Kakkonen, Maija ;
Tervo, Anu J. ;
Wittekindt, Carsten ;
Suuronen, Tiina ;
Kuusisto, Erkki ;
Jarvinen, Tomi ;
Salminen, Antero ;
Poso, Antti ;
Wallen, Erik A. A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) :7907-7911
[8]   N-(3-(4-hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors [J].
Kiviranta, Paivi H. ;
Leppanen, Jukka ;
Rinne, Valtteri M. ;
Suuronen, Tiina ;
Kyrylenko, Olga ;
Kyrylenko, Sergly ;
Kuusisto, Erkki ;
Tervo, Anu J. ;
Jarvinen, Tomi ;
Salminen, Antero ;
Poso, Antti ;
Wallen, Erik A. A. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (09) :2448-2451
[9]   Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (sirtuin) inhibitors [J].
Mai, A ;
Massa, S ;
Lavu, S ;
Pezzi, R ;
Simeoni, S ;
Ragno, R ;
Mariotti, FR ;
Chiani, F ;
Camilloni, G ;
Sinclair, DA .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7789-7795
[10]   Microplate filtration assay for nicotinamide release from NAD using a boronic acid resin [J].
McDonagh, T ;
Hixon, J ;
DiStefano, PS ;
Curtis, R ;
Napper, AD .
METHODS, 2005, 36 (04) :346-350